Citi analyst Joanne Wuensch lowered the firm’s price target on Intuitive Surgical (ISRG) to $590 from $635 and keeps a Neutral rating on the shares following the preliminary Q4 report. The firm views the announcement as inline with expectations.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026
- Closing Bell Movers: Intel falls 12% on soft guidance
- ISRG Earnings: Intuitive Surgical’s Financial Results Beat Wall Street’s Expectations
- Intuitive Surgical sees FY26 income tax rate 22%-23%
- Intuitive Surgical sees FY26 worldwide da Vinci procedure growth 13%-15%